The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Does Vitiligo Raise Risk for Mental Health Disorders?

A retrospective study shows that patients with vitiligo face a high burden of mental health disorders, with the morbidity profile matching that of atopic dermatitis but not psoriasis.

Obinutuzumab Lowers Lupus Disease Activity in Phase 3 Trial

Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.

SLIT Appears Safe and Effective for Dust Mite Allergy

House dust mite sublingual immunotherapy reduces symptoms, decreases medication use, and shows a favorable safety profile in adults and adolescents with allergic rhinoconjunctivitis.

Measles Cases in South Carolina Rise by 2 to 993, State Health Department Says

Measles cases in South Carolina rose to 993 on Tuesday, state health ⁠data showed, including two cases since the last update on Friday.

Shingles Vaccine Safe in Patients With Rheumatic Diseases

A herpes zoster vaccine is safe in adults with autoimmune rheumatic disease and elicits a strong immune response, but responses are weaker in those on rituximab or mycophenolate, per a phase 4 study.

Skin Inflammation Therapies Might Target Depression

Anti-inflammatory therapies that are highly effective for inflammatory skin diseases might also be relevant to depression because of shared inflammatory pathways.

Todays Updates

Chemoimmunotherapy Boosts Head and Neck Cancer Response

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

Todays Updates

Chemoimmunotherapy Boosts Head and Neck Cancer Response

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

Latest News

A retrospective study shows that patients with vitiligo face a high burden of mental health disorders, with the morbidity profile matching that of atopic dermatitis but not psoriasis.

Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.

House dust mite sublingual immunotherapy reduces symptoms, decreases medication use, and shows a favorable safety profile in adults and adolescents with allergic rhinoconjunctivitis.

Measles cases in South Carolina rose to 993 on Tuesday, state health ⁠data showed, including two cases since the last update on Friday.

A herpes zoster vaccine is safe in adults with autoimmune rheumatic disease and elicits a strong immune response, but responses are weaker in those on rituximab or mycophenolate, per a phase 4 study.

Anti-inflammatory therapies that are highly effective for inflammatory skin diseases might also be relevant to depression because of shared inflammatory pathways.

News All Time

Adrenocortical Carcinoma: Incidence and Survival Over Time

The incidence of adrenocortical carcinoma is stable over time, but the survival for stage IV disease has improved, with the centralisation of care being associated with better survival.

Doctors Raise Their Voices Against AMR

Healthcare professionals are stepping into the spotlight in Lifeline, a musical that blends medicine, music, and a warning about antimicrobial resistance.

Extended Dupilumab Dosing Maintains Efficacy in Nasal Polyps

Dupilumab yields rapid reductions in nasal polyp burden and improvements in smell function; these benefits persist with extended dosing intervals.

Immunoglobulin A Nephropathy: 5 Treatment Approaches to Know

The treatment landscape for IgA nephropathy is rapidly evolving, with therapies focused on mitigating the effects of nephron loss now being combined with immunomodulatory treatments.

Tolvaptan vs Fluid Limits: Do Costs Outweigh pNa Gains?

Although tolvaptan bests fluid restriction at raising plasma sodium concentration, 19% of patients experience overcorrection of sodium increases.

Outpatient RSV in Kids Younger Than 2 Has Distinct Features

In outpatient care, RSV infections in children younger than 2 years present with distinct clinical features and greater illness burden than infections caused by other respiratory viruses.

Pfizer's Eczema Drug Meets Main Goal in Mid-stage Trial, Plans Late-stage Study

U.S. drugmaker Pfizer said on Monday its experimental drug for a ⁠chronic skin disease met the main goal in a mid-stage study.

Gene Therapy Injections for Knee OA: Where Are We At?

Developers of gene therapies to treat knee osteoarthritis are taking the familiar intra-articular route to deliver proteins and molecules directly to the site of the disease.

Women at Higher Risk for Chronic Cough With Age

Experts report that a chronic cough lasting at least 8 weeks disproportionately affects women, with prevalence increasing with age.

FDA Approves Deucravacitinib as First TYK2 Inhibitor for PsA

In clinical trials, more than half of all patients treated with deucravacitinib achieved at least 20% improvement in American College of Rheumatology response criteria.

Risk Factors for Childbirth-Related PTSS Vary in Parents

Prenatal, childbirth-related, and postpartum risk factors drive childbirth-related posttraumatic stress symptoms, with subjective perception and infant health emerging as key predictors.

Fasting-Mimicking Diet Shows Benefit in Crohn’s Disease

Nearly 70% of patients with mild-to-moderate Crohn’s disease following a 5-day-per-month fasting-mimicking diet achieve a clinical response in a controlled trial.

Pediatric Rheumatologist Explains Updated ACR JIA Guidelines

The new draft guidelines favor earlier DMARD therapy with ‘much decreased reliance on glucocorticoids that have several side effects in growing children,’ said rheumatologist Susan Shenoi, MS.

Two Drugs Similarly Maintain EGPA Vasculitis Remission

‘There was no signal in favor of rituximab [vs azathioprine] even in patients at high risk for vasculitis relapse,’ said Xavier Puéchal, MD, PhD.

Multiple Vaccines Not Linked to Higher Risk for Reactions

The researchers tested simultaneous administration of routinely recommended vaccines against up to eight pathogens.

Exhaled Compounds May Identify Allergic Rhinitis

Volatile organic compounds in exhaled breath may help distinguish patients with allergic rhinitis from patients with nonallergic rhinitis.

Recommended News For You

Un nou sistem de endoscopică imaging are capacitatea de a detecta mai mulți fluorescent tracers.

New study reveals racial disparities in breast cancer diagnosis and outcomes in Canada

Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer

Adding cell-based vaccine to liver cancer therapy can slow cancer progression

Immunotherapy and targeted radiation shrink liver tumors, enabling surgery

Advances in "next generation" photoactive cancer therapy

Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer

Recommended Articles For You

Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System 

What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder 

A Mural of Thrombus: Unlocking the Power of Art to Combat Cardiovascular Disease 

Exploring the Potential of Bendamustine in Cancer Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Sickle Cell Disease Drug Pulled From Global Markets

2.

Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.

3.

Potential new therapy for childhood brain cancer could heal treatment-resistant tumors

4.

Lesser-known lobular breast cancer on the rise in U.S. women

5.

Millions of men could benefit from faster scan to diagnose prostate cancer

1.

Uncovering the Mysteries of the RDW Blood Test

2.

The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology

3.

An Overview Of Serum Osmolality: What Is It And How Can It Help You?

4.

TAR-200 in Bladder Cancer: Precision Drug Delivery Driving Oncology Advances

5.

Unveiling Canine Blood Clots Over Time: A Look at Low-Field MRI's Diagnostic Potential

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

2.

From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL

3.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

4.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

5.

Should We Use DARA Up Front As First-Line Therapy in MM?


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot